We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tenet Healthcare (THC) Registers a Bigger Fall Than the Market: Important Facts to Note
Read MoreHide Full Article
In the latest close session, Tenet Healthcare (THC - Free Report) was down 2.14% at $256.44. The stock's performance was behind the S&P 500's daily loss of 0.76%. On the other hand, the Dow registered a loss of 0.68%, and the technology-centric Nasdaq decreased by 1.13%.
Coming into today, shares of the hospital operator had lost 3.61% in the past month. In that same time, the Medical sector lost 3.03%, while the S&P 500 gained 1.26%.
The upcoming earnings release of Tenet Healthcare will be of great interest to investors. In that report, analysts expect Tenet Healthcare to post earnings of $4.59 per share. This would mark year-over-year growth of 24.05%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $5.47 billion, up 3.4% from the year-ago period.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $21.04 per share and revenue of $22.2 billion. These totals would mark changes of +25.39% and +4.18%, respectively, from last year.
Any recent changes to analyst estimates for Tenet Healthcare should also be noted by investors. Such recent modifications usually signify the changing landscape of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.3% upward. Right now, Tenet Healthcare possesses a Zacks Rank of #2 (Buy).
Looking at valuation, Tenet Healthcare is presently trading at a Forward P/E ratio of 12.45. This expresses no noticeable deviation compared to the average Forward P/E of 12.45 of its industry.
One should further note that THC currently holds a PEG ratio of 1. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Medical - Hospital industry currently had an average PEG ratio of 1.1 as of yesterday's close.
The Medical - Hospital industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 104, finds itself in the top 43% echelons of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow THC in the coming trading sessions, be sure to utilize Zacks.com.
View the Zacks #1 Rank List
Image: Bigstock
Tenet Healthcare (THC) Registers a Bigger Fall Than the Market: Important Facts to Note
In the latest close session, Tenet Healthcare (THC - Free Report) was down 2.14% at $256.44. The stock's performance was behind the S&P 500's daily loss of 0.76%. On the other hand, the Dow registered a loss of 0.68%, and the technology-centric Nasdaq decreased by 1.13%.
Coming into today, shares of the hospital operator had lost 3.61% in the past month. In that same time, the Medical sector lost 3.03%, while the S&P 500 gained 1.26%.
The upcoming earnings release of Tenet Healthcare will be of great interest to investors. In that report, analysts expect Tenet Healthcare to post earnings of $4.59 per share. This would mark year-over-year growth of 24.05%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $5.47 billion, up 3.4% from the year-ago period.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $21.04 per share and revenue of $22.2 billion. These totals would mark changes of +25.39% and +4.18%, respectively, from last year.
Any recent changes to analyst estimates for Tenet Healthcare should also be noted by investors. Such recent modifications usually signify the changing landscape of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.3% upward. Right now, Tenet Healthcare possesses a Zacks Rank of #2 (Buy).
Looking at valuation, Tenet Healthcare is presently trading at a Forward P/E ratio of 12.45. This expresses no noticeable deviation compared to the average Forward P/E of 12.45 of its industry.
One should further note that THC currently holds a PEG ratio of 1. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Medical - Hospital industry currently had an average PEG ratio of 1.1 as of yesterday's close.
The Medical - Hospital industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 104, finds itself in the top 43% echelons of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow THC in the coming trading sessions, be sure to utilize Zacks.com.